» Articles » PMID: 31956163

JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version

Citing Articles

A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective study.

Ito T, Fukui S, Nagase F, Yamaguchi T, Oda N, Inokuchi H Rheumatol Int. 2025; 45(3):45.

PMID: 39924612 DOI: 10.1007/s00296-025-05796-5.


Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis.

Sugihara T, Harigai M, Uchida H, Yoshifuji H, Maejima Y, Ishizaki J Arthritis Res Ther. 2025; 27(1):19.

PMID: 39891304 PMC: 11783758. DOI: 10.1186/s13075-025-03486-y.


Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with silicosis, alveolar hemorrhage, and rapidly progressive glomerulonephritis: a case report.

Mizuhashi K AME Case Rep. 2025; 9:8.

PMID: 39866275 PMC: 11760511. DOI: 10.21037/acr-24-112.


Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet's Disease from Immunological and Clinical Perspectives.

Naganuma M, Takeno M, Celik A, Moots R, Pinton P, Hisamatsu T Biomedicines. 2025; 13(1).

PMID: 39857830 PMC: 11761229. DOI: 10.3390/biomedicines13010247.


Efficacy of secukinumab in Takayasu arteritis with myocardial infarction complicated with generalized pustular psoriasis: A case report.

Asano T, Yoshida S, Matsuoka N, Ishikawa M, Sato A, Ogawa S Medicine (Baltimore). 2024; 103(51):e40994.

PMID: 39705455 PMC: 11666216. DOI: 10.1097/MD.0000000000040994.